Therapeutic Area: Dermatology
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Crescita Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Distribution Agreement January 20, 2020
The partnership with FILLMED will allow Crescita to expand its product offering in the medical aesthetic field with the addition of the hyaluronic acid ART-Filler® injectables range and NCTF® 135 HA.